Recent research focusing on Retatrutide at a dosage of 40mg is shedding new light on its potential benefits. Preliminary findings suggest that this higher dosage may boost the drug's ability to control blood levels, potentially offering greater outcomes for individuals with diabetes. Further study is underway to fully evaluate the long-term safety